Oak Ridge Investments’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-32,745
Closed -$3.59M 146
2023
Q4
$3.59M Buy
32,745
+10,514
+47% +$1.09M 0.41% 70
2023
Q3
$2.24M Sell
22,231
-771
-3% -$88.6K 0.29% 93
2023
Q2
$3.13M Sell
23,002
-742
-3% -$90.6K 0.39% 75
2023
Q1
$2.47M Sell
23,744
-1,281
-5% -$124K 0.33% 88
2022
Q4
$2.22M Sell
25,025
-714
-3% -$59.2K 0.33% 90
2022
Q3
$2.06M Sell
25,739
-187
-0.7% -$17.6K 0.31% 100
2022
Q2
$2.48M Sell
25,926
-19,368
-43% -$2.32M 0.36% 88
2022
Q1
$6.73M Sell
45,294
-24,240
-35% -$3.38M 0.75% 36
2021
Q4
$9.86M Sell
69,534
-2,346
-3% -$332K 0.83% 39
2021
Q3
$9.4M Sell
71,880
-2,298
-3% -$301K 0.83% 36
2021
Q2
$10.2M Sell
74,178
-5,087
-6% -$696K 0.89% 30
2021
Q1
$10.4M Sell
79,265
-1,510
-2% -$182K 0.96% 25
2020
Q4
$9.05M Sell
80,775
-21,135
-21% -$2M 0.8% 37
2020
Q3
$8.02M Sell
101,910
-6,896
-6% -$562K 0.62% 48
2020
Q2
$7.83M Sell
108,806
-8,616
-7% -$599K 0.66% 53
2020
Q1
$6.72M Sell
117,422
-20,890
-15% -$1.93M 0.69% 52
2019
Q4
$15.5M Sell
138,312
-12,616
-8% -$1.34M 1.13% 26
2019
Q3
$14.5M Buy
150,928
+48,131
+47% +$4.52M 1.09% 31
2019
Q2
$8.8M Buy
+102,797
New +$8.45M 0.61% 70

Other funds holding CNMD

Oak Ridge Investments's CNMD Position: Q1 2024 in Review

Oak Ridge Investments sold out of CONMED (CNMD) in Q1 2024, closing a stake of 32,745 shares — an estimated $3.59M sold.

Oak Ridge Investments first reported a position in CNMD in Q2 2019 and held it in 19 quarters. The position peaked at $15.5M in Q4 2019. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

  • Oak Ridge Investments reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
  • Oak Ridge Investments sold 32,745 CONMED shares in Q1 2024, an estimated $3.59M.
  • Oak Ridge Investments first reported a position in CONMED in Q2 2019 and held it in 19 quarters.
  • Oak Ridge Investments's CONMED position peaked at $15.5M in Q4 2019.
  • 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on Oak Ridge Investments's 13F filing for Q1 2024, filed 1 May 2024.